🇺🇸 FDA
Patent

US 7226602

Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 7226602 (Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/5256, A61K2039/54